中新网宜兴4月23日电 (孙权)诺贝尔医学生理学奖获得者理查·罗伯茨23日携国内外多位长期从事肿瘤临床生物治疗研究的专家与江苏宜兴经济开发区签约“结盟”，合作成立了理查·罗伯茨生物科技中国(宜兴)研究院肿瘤临床研究应用国际合作中心。根据计划，这个中心将主打“国际化”市场，以期走出一条肿瘤学研究和临床治疗发展的新模式。

中新网yixing4月23日电 (Sun quan)The Nobel Prize winner of medical physiology with Richard Roberts, 23, a number of long-term engaged in the biological treatment of clinical oncology research at home and abroad experts signed a contract with jiangsu yixing economic development zone"An alliance",Biological science and technology of China co-operation set up Richard Roberts(yixing)Institute of oncology research application international cooperation center.According to the plan,The center will be the main"The internationalization"The market,To blaze a trail of oncology research and clinical treatment of the development of the new model.

　　据了解，近10年来世界范围内肿瘤治疗都取得了长足的进步，但仍然面临许多困境。手术治疗对微小癌灶、转移癌灶束手无策，放化疗对正常细胞核癌细胞区分不够、毒副作用较大等难题依旧困扰着医学工作者。因此，靶向性强、无明显副作用活副作用较小的一些新型肿瘤治疗方法愈发受到人们的广泛关注。

据了解,World within the scope of tumor therapy in recent 10 years has made great progress,But still faces many difficulties.Surgery for small carcinoma of the oven/Metastatic carcinoma to do oven,Radiation and chemotherapy to the distinction between normal nucleus cancerous cells was not enough/毒副作用较大, etc.难题依旧困扰着医学工作者.so,Targeted strong/No obvious side effects live less side effect of some new tumor treatment method has received extensive attention of people.

　　今日到会的上海交通大学免疫学研究所研究员李宇博士称，尽管目前中国在肿瘤治疗方面也取得了很多成绩，但在肿瘤的研究和临床治疗方面与国际先进水平仍有一定差距，要使这方面赶超世界先进水平，引进肿瘤的研究和临床治疗方面的高水平人才和技术是有效步骤。他同时希望引进的创新人才能够突破以往研究的局限，走出一条不同的“治癌路”。

今日到会的上海交通大学免疫学研究所研究员李宇博士称,Although China is now also a lot of achievements in tumor treatment,But in cancer research and clinical treatment with the international advanced level there is still a certain gap,To make it catch up with the world advanced level,In cancer research and clinical treatment of high level talents and technology are effective steps.He also wants to introduce innovative talents can break through the limitations of previous research,Out of a different"Cancer treatment way".

　　记者了解到，此番成立的肿瘤临床研究应用国际合作中心在利用宜兴本地医院的临床肿瘤样本资源与国际同行开展国际肿瘤研究合作的同时，重点就是引进、吸纳国内外肿瘤学高级人才到宜兴进行研发，力争成为一座国际高级肿瘤学人才进入中国的桥梁。

记者了解到,This established international cooperation center of application of cancer clinical research in the use of yixing local hospital clinical tumor samples resources cooperation with international counterparts to carry out the international cancer research at the same time,Focus is introduced/Senior talent to yixing to absorb domestic and foreign oncology research,Strive to become a bridge of international advanced oncology talents into China.

　　作为肿瘤临床研究应用国际合作中心的“领头羊”，理查·罗伯茨提出，该中心成立后将更“青睐”中青年科学家，因为年轻人富有创造力，在科研道路上可以犯错的“机会”多，也较容易取得成绩。

作为肿瘤临床研究应用国际合作中心的"A leader",Richard Roberts is put forward,After the establishment of the center will be more"In favor of"Young and middle-aged scientists,Because creative young people,In scientific research can make a mistake on the road"opportunity"More than,Also relatively easy to gain success.

　　宜兴市委常委、组织部部长崔荣国在今天的会上介绍了当地招才引智的相关政策与措施。他表示，在结合无锡大市范围内的引才优惠政策后，江苏宜兴此前已开始实施“陶都英才工程”，对前往当地创业就业的高层次人才给予人民币100万到3000万不等的个人、项目支持。

yixing市委常委/Organization department minister Cui Rongguo in today's meeting local ZhaoCaiYinZhi related policies and measures are introduced.He said,Within the scope of the market in wuxi of preferential policies to attract,Jiangsu yixing had already started"Capital, talent project",对前往当地创业就业的高层次人才给予人民币100万到3000万不, etc.的个人/Project support.

　　据悉，理查·罗伯茨生物科技中国(宜兴)研究院肿瘤临床研究应用国际合作中心目前已有意“联姻”国际同行开展利用蛋白组学和蛋白磷酸化通路分析进行肿瘤靶际的研究，并计划共同在国际学术杂志上发布学术论文。通过中心推荐，宜兴当地还可选派本地肿瘤医院的肿瘤学医生或相关研究人员去美国著名肿瘤学研究和治疗机构进修学习等。(完)

据悉,Richard Roberts biological science and technology of China(yixing)Institute of oncology research application international cooperation center has been intentionally"marriage"International counterparts to carry out the use of proteomics and the analysis of protein phosphorylation pathway for tumor target international research,And are planning to publish academic papers on international journals.Through the center recommended,yixing当地还可选派本地肿瘤医院的肿瘤学医生或相关研究人员去美国著名肿瘤学研究和治疗机构进修学习, etc..(After the)